Oh-Biologika-2023-28 - Lenograstim. The Health Insurance Companies Involved Pursue The Goal Of Concluding Discount Agreements With All Suitable Pharmaceutical Companies In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient Lenograstim. The Contract Is Concluded As Part Of The Openhousebiologica Process Of The Participating Health Insurance Companies: There Are No Individual Negotiations About Contract Content; Uniform Conditions Apply. The Health Insurance Companies Involved Do Not Guarantee Individual Contractual Partners Any Exclusivity. The Contract Term Is A Maximum Of 24 Months Starting On January 1St, 2024. The Contract Ends On December 31, 2025 At The Latest, Regardless Of The Date The Contract Was Concluded. All Further Information Can Be Found In The Participation And Contract Documents.
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 70654089
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.
